At the time of writing, Rocket Pharmaceuticals Inc [RCKT] stock is trading at $10.58, down -1.21%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The RCKT shares have gain 4.13% over the last week, with a monthly amount drifted -9.42%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Rocket Pharmaceuticals Inc [NASDAQ: RCKT] stock has seen the most recent analyst activity on December 30, 2024, when Wedbush initiated its Outperform rating and assigned the stock a price target of $32. Previously, Jefferies started tracking the stock with Buy rating on December 18, 2024, and set its price target to $29. On October 16, 2024, Scotiabank initiated with a Sector Outperform rating. Goldman started tracking the stock assigning a Neutral rating and suggested a price target of $39 on April 02, 2024. Cantor Fitzgerald initiated its recommendation with a Overweight and recommended $65 as its price target on October 24, 2023. Morgan Stanley started tracking with a Overweight rating for this stock on February 01, 2023, and assigned it a price target of $45. In a note dated November 08, 2022, Canaccord Genuity initiated an Buy rating and provided a target price of $53 on this stock.
For the past year, the stock price of Rocket Pharmaceuticals Inc fluctuated between $10.07 and $31.47. Currently, Wall Street analysts expect the stock to reach $38.67 within the next 12 months. Rocket Pharmaceuticals Inc [NASDAQ: RCKT] shares were valued at $10.58 at the most recent close of the market. An investor can expect a potential return of 265.5% based on the average RCKT price forecast.
Analyzing the RCKT fundamentals
Gross Profit Margin for this corporation currently stands at 0.05% with Operating Profit Margin at -26.55%, Pretax Profit Margin comes in at -25.03%, and Net Profit Margin reading is -25.03%. To continue investigating profitability, this company’s Return on Assets is posted at -0.66, Equity is -0.63 and Total Capital is -0.77. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.08.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 10.27 points at the first support level, and at 9.97 for the second support level. However, for the 1st resistance point, the stock is sitting at 10.81, and for the 2nd resistance point, it is at 11.04.
Ratios To Look Out For
It is important to note that Rocket Pharmaceuticals Inc [NASDAQ:RCKT] has a current ratio of 6.05. In addition, the Quick Ratio stands at 6.05 and the Cash Ratio stands at 1.64.
Transactions by insiders
Recent insider trading involved Militello John,, that happened on Jan 23 ’25 when 896.0 shares were sold. Officer, Militello John completed a deal on Jan 23 ’25 to buy 896.0 shares. Meanwhile, Militello John sold 1224.0 shares on Nov 21 ’24.
